Cellular Materials
Our cells make your research possible
Ethically sourced from full-term, healthy donors under IRB-approved protocols. Fully characterized with Certificates of Analysis.
Cord-derived materials for research and clinical programs
Organized by intended use — from research starting materials to co-development opportunities. Custom specifications and pooled-donor formats available on request.
Unprocessed and minimally processed cord-derived material for downstream isolation, expansion, and IND-enabling work.
Cord Blood
Whole units from single donors. Sized by TNC for scale-up programs.
Cord Tissue
Wharton's Jelly from umbilical cord segments. Source for MSC isolation.
Isolated cell populations characterized for research applications.
MSCs
Mesenchymal stromal cells from umbilical cord tissue.
Available for partnership programs. Intended for future clinical studies or therapy products.
CD34+ HSPCs
Hematopoietic stem and progenitor cells. Positively selected, ≥90% purity.
MSC Exosomes
Extracellular vesicles isolated from Wharton's Jelly MSCs. Sized, counted, and characterized.
Cord Blood Cellular Therapy Product
Cord blood-derived cellular therapy product for partnership programs and translational pipelines.
Applications
From early-stage discovery to IND-enabling programs across academic and biopharma research.
Cell & Gene Therapy Development
IND-enabling programs using clinical-grade cord blood and cord tissue starting materials.
HSC & MSC Isolation
Hematopoietic and mesenchymal stem cell isolation from characterized, donor-screened sources.
iPSC Reprogramming
Cord blood-derived cells as starting material for induced pluripotent stem cell generation.
Exosome Research
MSC-derived exosome isolation and characterization for therapeutic and diagnostic use.
Regenerative Medicine
Tissue engineering, wound healing, and regenerative therapy development.
Immunology & Translational Medicine
Immune profiling, GvHD research, and translational immunotherapy programs.
From Testing to Delivery
Every unit undergoes full release testing before clinical use. Our quality systems ensure product consistency, safety, and regulatory compliance from processing through delivery.
| Test Category | Description |
|---|---|
| Identity | Confirmation of cell type and donor identity |
| Potency | Assessment of viable cell content and functional capacity |
| Viability | Cell viability determination post-processing and post-thaw |
| Sterility | Microbiological testing to confirm absence of contamination |
| HLA Typing | High-resolution human leukocyte antigen characterization |
Units undergo controlled-rate cryopreservation with continuous temperature monitoring and automated alerts. Shipped in validated containers that maintain required temperature ranges throughout transit, with domestic and international distribution to transplant centers.
A short checklist
Materials are released for research and partnership programs. Confirm these on your side so the transfer goes smoothly.
Confirm cryogenic capability
Your facility can receive and store materials below -150°C. Once released, they can't return to our inventory.
Plan transport and customs
You handle shipment logistics, customs clearance, and final disposition. We can recommend cryogenic carriers.
Have your approvals ready
IRB, IBC, or equivalent oversight documentation, plus any import/export permits for your region.
Use is research / partnership only
Materials ship as is, without warranties. Receiving them isn't authorization for clinical or therapeutic use.
Facility inquiries
Questions about manufacturing capabilities, quality systems, or product specifications.
Contact our team